Other studies showed that CurE was able to chemo-sensitize colon tumor cells by regulating TFAP4/Wnt/beta-catenin signaling [37] and inhibit the proliferation of pancreatic adenocarcinoma cells by modulating STAT3 signaling [38]. Here, CTNNB1 is linked to pancreatic adenocarcinoma.